*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.
Hyperlipidemia is an important risk factor for coronary heart disease. Dr. Dayspring will discuss the physiology of lipoprotein metabolism, emphasizing the role of triglycerides in creating apoB and apoA-I particles and the diagnosis of lipoprotein pathology typical of obese patients.
Disclosures (at time of recording):
Thomas Dayspring, MD, FACP, FNLA, NCMP: Health Diagnostic Lab: Consultant; GlaxoSmithKline: Lecture Bureau; Kowa Pharmaceuticals: Consultant
William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia
Nothing to Disclose: Heidi Gordon, Dana Mansell; Stacy Schmidt, PhD; Jennifer Seger, MD, FOMA; Harold Seim, MD, MPH, FOMA; Laurie Traetow, CAE
July 11, 2017
December 30, 2020 12:00 AM
Elucidate the role of lipoproteins in lipid metabolism and how obesity can lead to lipid dysfunction and the development of atherosclerosis.
Cookies are small pieces of information that are stored by your browser on your computer’s hard drive.
You can delete or block cookies within your browser settings.
Should you opt to do this, some parts of our site may not work.
For more information, including instructions on how to remove the cookies that have been placed,